Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811180) titled 'Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells - Intensive Care Unit' on Sept. 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Vanderbilt University Medical Center
Condition:
Glucose
Metabolism
Isotope Labeling
Immune System and Related Disorders
Critical Illness
Intensive Care Unit (ICU)
Sepsis
Intervention:
Drug: 13C6-Glucose
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: November 1, 2026
Target Sample Size: 25
Countries of R...